Synthesis and HIV-1 integrase inhibition activity of some N-arylindoles

Chemical and Pharmaceutical Bulletin

Volumn 56, Issue 5, 2008, Pages 720-722

  Xu, Hui ^a   Liu, Wu Qing ^b   Fan, Ling Ling ^a   Chen, Yang ^a   Yang, Liu Meng ^b   Lv, Lei ^a   Zheng, Yong Tang ^b  

^a NORTHWEST A F UNIVERSITY   (China)

^b KUNMING INSTITUTE OF ZOOLOGY   (China)

Author keywords

Anti human immunodeficiency virus type 1; Integrase inhibitor; N arylindole; Synthesis

Indexed keywords

INDOLE DERIVATIVE; INTEGRASE; N (2 CYANOPHENYL)INDOLE; N (2 NITROPHENYL)INDOLE; ZIDOVUDINE;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG SYNTHESIS; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; STRUCTURE ACTIVITY RELATION;

CELL LINE; CELL SURVIVAL; CHROMATOGRAPHY, THIN LAYER; GIANT CELLS; HIV INTEGRASE INHIBITORS; HIV-1; HUMANS; INDICATORS AND REAGENTS; INDOLES; MAGNETIC RESONANCE SPECTROSCOPY; MASS SPECTROMETRY; STRUCTURE-ACTIVITY RELATIONSHIP; TETRAZOLIUM SALTS; THIAZOLES;

EID: 43449130922     PISSN: 00092363     EISSN: 13475223     Source Type: Journal    
DOI: 10.1248/cpb.56.720     Document Type: Article

References (14)

1. Johston M. I., Hoth D. F., Science, 260, 1286-1293 (1993).
2. Von Angerer E., Strohmeier J., J. Med. Chem., 30, 131-136 (1987).
3. Glamkowski E. J., Fortunato J. M., Spaulding T. C., Wilker J. C., Ellis D. B., J. Med. Chem., 28, 66-73 (1985).
4. Perregaard J., Arnt J., Boegesoe K. P., Hyttel J., Sanchez C., J. Med. Chem., 35, 1092-1101 (1992).
5. Unangst P. C., Carethers M. E., Webster K., Janik G. M., Robichaud L. J., J. Med. Chem., 27, 1629-1633 (1984).
6. Cole D. C., Ellingboe J. W., Lennox W. J., Mazandarani H., Smith D. L., Stock J. R., Zhang G. M., Zhou P., Schechter L. E., Bioorg. Med. Chem. Lett., 15, 379-383 (2005).
7. Li Q., Li T. M., Woods K. W., Gu W. Z., Cohen J., Stoll V. S., Galicia T., Hutchins C., Frost D., Rosenberg S. H., Sham H. L., Bioorg. Med. Chem. Lett., 15, 2918-2922 (2005).
8. Merino I., Monge A., Font M., Martinez de Irujo J. J., Alberdi E., Santiago E., Prieto I., Lasarte J. J., Sarobe P., Borras F., Il Farmaco, 54, 255-264 (1999).
9. Xu H., Zhang X., Tian X., Lu M., Wang Y. G., Chem. Pharm. Bull., 50, 399-402 (2002).
10. Hui X., Desrivot J., Bories C., Loiseau P. M., Franck X., Hocquemiller R., Figadere B., Bioorg. Med. Chem. Lett., 16, 815-820 (2006).
11. Xu H., Jian K. Z., Guan Q., Ye F., Lv M., Chem. Pharm. Bull., 55, 1755-1757 (2007).
12. Zhang G. H., Wang Q., Chen J. J., Zhang X. M., Tam S. C., Zheng Y. T., Biochem. Biophys. Res. Commun., 334, 812-816 (2005).
13. Zheng Y. T., Zhang W. F., Ben K. L., Wang J. H., Immunopharmacol. Immunotoxicol., 17, 69-79 (1995).
14. Wang Q., Ding Z. H., Liu J. K., Zheng Y. T., Antiviral Res., 64, 189-194 (2004).